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Background
Innate chemokines secreted from cord blood mononuc-
lear cells (CBMCs) offer novel tools to investigate the
influence of immune deviation at birth to the develop-
ment of eczema or wheeze by 2 years of age.
Methods
Cord blood samples were collected from 161 subjects from
a birth cohort of 253 subjects participating in a double-
blind placebo randomized trial on probiotic supplementa-
tion (Lactobacillus rhamnosus GG and Bifidobacteria
longum, birth to 6 months). Clinical symptoms for eczema
and wheeze were followed up to 2 years of age. The che-
mokine production in culture supernatants from CBMCs
stimulated with 1 ug/mL of lipopolysaccharides (LPS) for
24 hours was measured using the Milliplex assay. Chemo-
kine levels were analyzed by the Mann-Whitney UTest
and the association of chemokines with clinical outcomes
was analyzed by the multivariable logistic regression.
Results
Our results showed that subjects with eczema (n = 36) had
significantly reduced production of CXCL5 (epithelial neu-
trophil-activating protein 78 (ENA78)) from CBMCs as
compared to healthy control subjects (n = 94) from the
LPS stimulated cells (p = 0.001). CCL20 (macrophage
inflammatory protein-3a) levels were significantly lower in
the subjects who developed wheeze (n = 35) as compared
to healthy controls (n = 94) from the LPS stimulated cells
(p = 0.001). There was no difference in CXCL5 and
CCL20 production from the cultured unstimulated cells.
Diminished CXCL5 production by LPS stimulated
CBMCs was found to be independently associated with
eczema (adjusted OR, 0.275; 95% CI, 0.134-0.562, p =
0.001) after adjusting for allergen sensitization, paternal
eczema and sibling eczema using multivariable logistic
regression. Similarly, suppressed production of LPS stimu-
lated CCL20 was an independent risk factor associated to
the development of wheeze (adjusted OR, 0.308; 95% CI,
0.133-0.716, p= 0.06) after adjustment for maternal
asthma, sibling eczema, birth height and birth weight.
Conclusions
We observed the diminished production of CXCL5 and
CCL20 by CBMCs from subjects who develop eczema
and wheeze respectively within 2 years of age. This asso-
ciation may reflect a deviated innate immune response
to microbial or viral infections which might have an
impact on the susceptibility of childhood eczema and
wheeze.
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